Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?
11:26am, Wednesday, 01'st Apr 2026
ADMA rides on surging Asceniv demand, expanding payer coverage, and stronger plasma supply deals to drive rapid revenue growth through 2027.
ADMA Biologics guided 2026 revenue to at least $635 million -- built on a 2025 revenue base a short-seller report alleges was inflated by as much as 23 percentage points. NEW YORK, April 1, 2026 /PRNe
NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti and Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) for potential violations of th
Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors
06:46pm, Tuesday, 31'st Mar 2026
The latest trading day saw Adma Biologics (ADMA) settling at $9.01, representing a -1.53% change from its previous close.
ADMA SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
06:00pm, Tuesday, 31'st Mar 2026
NEW YORK, March 31, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ:ADMA)
ADMA Securities News: ADMA Biologics Investigated for Securities Fraud After Culper Research Report Revelation Sparks 29% Stock Drop
06:07am, Tuesday, 31'st Mar 2026
BFA Law is investigating ADMA Biologics after its stock plummeted 29% due to Culper Research channel stuffing claims, potentially violating federal securities laws. NEW YORK, March 31, 2026 /PRNewswir
SAN FRANCISCO, March 30, 2026 /PRNewswire/ -- Investors in ADMA Biologics, Inc. (NASDAQ: ADMA) saw the price of their shares slide over 16% on March 24, 2026 on short seller Culper Research's report,
NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the f
Levi & Korsinsky Launches Fraud Investigation on Behalf of ADMA Biologics, Inc. (ADMA) Shareholders
12:10am, Monday, 30'th Mar 2026
New York, New York--(Newsfile Corp. - March 30, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into ADMA Biologics, Inc. ("ADMA Biologics, Inc.") (NASDAQ: ADMA) con
ADMA Biologics (NASDAQ:ADMA) Shares Gap Up – Here’s What Happened
02:40am, Sunday, 29'th Mar 2026
ADMA Biologics Inc (NASDAQ: ADMA - Get Free Report)'s share price gapped up before the market opened on Friday. The stock had previously closed at $8.29, but opened at $9.47. ADMA Biologics shares las
ADMA Biologics Sees Unusually High Options Volume (NASDAQ:ADMA)
01:13am, Saturday, 28'th Mar 2026
ADMA Biologics Inc (NASDAQ: ADMA - Get Free Report) was the target of unusually large options trading on Thursday. Stock traders bought 22,398 call options on the stock. This represents an increase of
SAN FRANCISCO, March 27, 2026 (GLOBE NEWSWIRE) -- Investors in ADMA Biologics, Inc. (NASDAQ: ADMA) saw the price of their shares slide over 16% on March 24, 2026 on short seller Culper Research's rep
ADMA BIOLOGICS, INC. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
08:00pm, Friday, 27'th Mar 2026
NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ:ADMA). The investigation concern
Why Is Adma Biologics (ADMA) Down 45.4% Since Last Earnings Report?
12:32pm, Friday, 27'th Mar 2026
Adma Biologics (ADMA) reported earnings 30 days ago. What's next for the stock?
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In ADMA To Contact Him Directly To Discuss Their Options
